Jager MJ - Search Results

1

Analysis of inflammatory cells in uveal melanoma after prior irradiation.

Vu TH, Bronkhorst IH, Versluis M, Marinkovic M, van Duinen SG, Vrolijk J, Luyten GP, Jager MJ. Vu TH, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2013 Jan 14;54(1):360-9. doi: 10.1167/iovs.12-9424. Invest Ophthalmol Vis Sci. 2013. PMID: 23211827

2

Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.

All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager MJ, Larsson O. All-Ericsson C, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2002 Jan;43(1):1-8. Invest Ophthalmol Vis Sci. 2002. PMID: 11773005

3

HLA expression in uveal melanoma: there is no rule without some exception.

Jager MJ, Hurks HM, Levitskaya J, Kiessling R. Jager MJ, et al. Hum Immunol. 2002 Jun;63(6):444-51. doi: 10.1016/s0198-8859(02)00389-0. Hum Immunol. 2002. PMID: 12039519 Review.

4

Heat shock protein expression in the eye and in uveal melanoma.

Missotten GS, Journée-de Korver JG, de Wolff-Rouendaal D, Keunen JE, Schlingemann RO, Jager MJ. Missotten GS, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3059-65. doi: 10.1167/iovs.02-1038. Invest Ophthalmol Vis Sci. 2003. PMID: 12824252

5

Prognostic value of S-100-beta serum concentration in patients with uveal melanoma.

Missotten GS, Tang NE, Korse CM, Hurks HM, de Wolff-Rouendaal D, Keunen JE, Jager MJ, Bonfrer JM. Missotten GS, et al. Among authors: jager mj. Arch Ophthalmol. 2003 Aug;121(8):1117-9. doi: 10.1001/archopht.121.8.1117. Arch Ophthalmol. 2003. PMID: 12912688

6

Prognostic value of the disodium phosphate 32P uptake test in uveal melanoma: a long-term study.

Overkleeft EN, Zuidervaart W, Hurks HM, Eilers PH, de Wolff-Rouendaal D, Jager MJ. Overkleeft EN, et al. Among authors: jager mj. Arch Ophthalmol. 2003 Oct;121(10):1398-403. doi: 10.1001/archopht.121.10.1398. Arch Ophthalmol. 2003. PMID: 14557175

7

Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens.

van Dinten LC, Pul N, van Nieuwpoort AF, Out CJ, Jager MJ, van den Elsen PJ. van Dinten LC, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2005 Jan;46(1):24-30. doi: 10.1167/iovs.04-0961. Invest Ophthalmol Vis Sci. 2005. PMID: 15623750

8

Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.

Notting IC, Buijs JT, Que I, Mintardjo RE, van der Horst G, Karperien M, Missotten GS, Jager MJ, Schalij-Delfos NE, Keunen JE, van der Pluijm G. Notting IC, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2005 May;46(5):1581-7. doi: 10.1167/iovs.04-0245. Invest Ophthalmol Vis Sci. 2005. PMID: 15851554

9

In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.

Li Y, Wang J, Rizvi SM, Jager MJ, Conway RM, Billson FA, Allen BJ, Madigan MC. Li Y, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4365-71. doi: 10.1167/iovs.05-0559. Invest Ophthalmol Vis Sci. 2005. PMID: 16303921

10

HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.

Maat W, Haasnoot GW, Claas FH, Schalij-Delfos NE, Schreuder GM, Jager MJ. Maat W, et al. Among authors: jager mj. Invest Ophthalmol Vis Sci. 2006 Jan;47(1):3-6. doi: 10.1167/iovs.05-1122. Invest Ophthalmol Vis Sci. 2006. PMID: 16384937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page